Brief: Xintela Receives 1 Million Sek From Vinnova
08/05/2020 06:32
May 8 (Reuters) - Xintela AB XINT.ST :
* XINTELA GRANTED 1 MILLION SEK FROM VINNOVA
* GRANT CONCERNS FUNDING OF A PRECLINICAL STUDY TO EVALUATE
XINTELA'S STEM CELLS FOR TREATMENT OF COVID-19 PATIENTS WITH
FATAL DISEASE CONDITION ARDS
Source text for Eikon: ID:nBQN1FQWCj
Further company coverage: XINT.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Xintela AB
See all newsBrief: Xintela To Raise SEK 30 Mln Via Convertible Loan From Flerie Invest
Advisory: Alerts on Xintela's phase I/IIa XSTEM results withdrawn
Brief: Xintela Q1 2026 Loss Before Tax SEK 11.8 Mln
Brief: Xintela Study Finds XSTEM Treatment Safe, Well Tolerated
Brief: Xintela Gets U.S. Patent For Xstem Treatment Of Difficult-To-Heal Wounds, Skin Defects